Long-term Update of U.S. GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Concurrent Chemoradiation with 5FU-Mitomycin Yields Better Disease-Free and Overall Survival than 5FU-Cisplatin

Reporter: Surbhi Grover, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 3 de octubre del 2011

Translation for this article does not exist